caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1982640223

Bruce Wilkoff

Clinical Cardiac ElectrophysiologyCleveland, OHI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Bruce Wilkoff's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 36 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Charlotte Palagyi
Nurse Practitioner · Cleveland, OH
68134
Omar Lababede
Diagnostic Radiology · Cleveland, OH
67129
Ajay Bhargava
Cardiology · Cleveland, OH
59140
SCHIAVONE, WILLIAM5194
Ryo Benson
Diagnostic Radiology · Cleveland, OH
3278
Ruchi Yadav
Diagnostic Radiology · Cleveland, OH
3268
TARAKJI, KHALDOUN2993
Rahul Renapurkar
Diagnostic Radiology · Cleveland, OH
2862
NPI 13967878672888
Joseph Azok
Diagnostic Radiology · Cleveland, OH
2743
John Stephens
Cardiology · Berkley, MI
2646
Michael Faulx
Cardiology · Cleveland, OH
2649
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
84.6
Quality
74.5
Cost
75.0
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.40%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
15
Beneficiaries
—
Total drug cost
$16K
Distinct drugs
1
Brand share
100.0%
Top prescribed drugs
Apixaban15 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.